C153H317N27O7 — CID 157440951
1-tert-butyl-N,N-dimethylpiperidin-4-amine;1-tert-butyl-4-methylpiperazine;4-tert-butylmorpholine;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-ol;1-tert-butylpiperidin-4-one;4-(1-tert-butylpiperidin-4-yl)-2,6-dimethylmorpholine;1-(1-tert-butylpiperidin-4-yl)-4-methylpiperazine;4-(1-tert-butylpiperidin-4-yl)morpholine;1-(1-tert-butylpiperidin-4-yl)piperazine;2-[4-(1-tert-butylpiperidin-4-yl)piperazin-1-yl]ethanol;1-(1-tert-butylpiperidin-4-yl)-4-propan-2-ylpiperazine;1-tert-butyl-4-propan-2-ylpiperazine (PubChem CID 157440951) has the molecular formula C153H317N27O7 and a molecular weight of 2647.40 g/mol. Its IUPAC name is 1-tert-butyl-N,N-dimethylpiperidin-4-amine;1-tert-butyl-4-methylpiperazine;4-tert-butylmorpholine;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-ol;1-tert-butylpiperidin-4-one;4-(1-tert-butylpiperidin-4-yl)-2,6-dimethylmorpholine;1-(1-tert-butylpiperidin-4-yl)-4-methylpiperazine;4-(1-tert-butylpiperidin-4-yl)morpholine;1-(1-tert-butylpiperidin-4-yl)piperazine;2-[4-(1-tert-butylpiperidin-4-yl)piperazin-1-yl]ethanol;1-(1-tert-butylpiperidin-4-yl)-4-propan-2-ylpiperazine;1-tert-butyl-4-propan-2-ylpiperazine.
| Compound Name | 1-tert-butyl-N,N-dimethylpiperidin-4-amine;1-tert-butyl-4-methylpiperazine;4-tert-butylmorpholine;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-ol;1-tert-butylpiperidin-4-one;4-(1-tert-butylpiperidin-4-yl)-2,6-dimethylmorpholine;1-(1-tert-butylpiperidin-4-yl)-4-methylpiperazine;4-(1-tert-butylpiperidin-4-yl)morpholine;1-(1-tert-butylpiperidin-4-yl)piperazine;2-[4-(1-tert-butylpiperidin-4-yl)piperazin-1-yl]ethanol;1-(1-tert-butylpiperidin-4-yl)-4-propan-2-ylpiperazine;1-tert-butyl-4-propan-2-ylpiperazine |
|---|---|
| PubChem CID | 157440951 |
| Molecular Formula | C153H317N27O7 |
| Molecular Weight | 2647.40 g/mol |
| Exact Mass | 2645.53 |
| IUPAC Name | 1-tert-butyl-N,N-dimethylpiperidin-4-amine;1-tert-butyl-4-methylpiperazine;4-tert-butylmorpholine;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-ol;1-tert-butylpiperidin-4-one;4-(1-tert-butylpiperidin-4-yl)-2,6-dimethylmorpholine;1-(1-tert-butylpiperidin-4-yl)-4-methylpiperazine;4-(1-tert-butylpiperidin-4-yl)morpholine;1-(1-tert-butylpiperidin-4-yl)piperazine;2-[4-(1-tert-butylpiperidin-4-yl)piperazin-1-yl]ethanol;1-(1-tert-butylpiperidin-4-yl)-4-propan-2-ylpiperazine;1-tert-butyl-4-propan-2-ylpiperazine |
| SMILES | CC(=O)N1CCN(C(C)(C)C)CC1.CC(C)(C)N1CCC(=O)CC1.CC(C)(C)N1CCC(N2CCN(CCO)CC2)CC1.CC(C)(C)N1CCC(N2CCNCC2)CC1.CC(C)(C)N1CCC(N2CCOCC2)CC1.CC(C)(C)N1CCC(O)CC1.CC(C)(C)N1CCOCC1.CC(C)N1CCN(C(C)(C)C)CC1.CC(C)N1CCN(C2CCN(C(C)(C)C)CC2)CC1.CC1CN(C2CCN(C(C)(C)C)CC2)CC(C)O1.CN(C)C1CCN(C(C)(C)C)CC1.CN1CCN(C(C)(C)C)CC1.CN1CCN(C2CCN(C(C)(C)C)CC2)CC1 |
| InChI | InChI=1S/C16H33N3.C15H31N3O.C15H30N2O.C14H29N3.C13H27N3.C13H26N2O.2C11H24N2.C10H20N2O.C9H20N2.C9H19NO.C9H17NO.C8H17NO/c1-14(2)17-10-12-18(13-11-17)15-6-8-19(9-7-15)16(3,4)5;1-15(2,3)18-6-4-14(5-7-18)17-10-8-16(9-11-17)12-13-19;1-12-10-16(11-13(2)18-12)14-6-8-17(9-7-14)15(3,4)5;1-14(2,3)17-7-5-13(6-8-17)16-11-9-15(4)10-12-16;1-13(2,3)16-8-4-12(5-9-16)15-10-6-14-7-11-15;1-13(2,3)15-6-4-12(5-7-15)14-8-10-16-11-9-14;1-11(2,3)13-8-6-10(7-9-13)12(4)5;1-10(2)12-6-8-13(9-7-12)11(3,4)5;1-9(13)11-5-7-12(8-6-11)10(2,3)4;1-9(2,3)11-7-5-10(4)6-8-11;2*1-9(2,3)10-6-4-8(11)5-7-10;1-8(2,3)9-4-6-10-7-5-9/h14-15H,6-13H2,1-5H3;14,19H,4-13H2,1-3H3;12-14H,6-11H2,1-5H3;13H,5-12H2,1-4H3;12,14H,4-11H2,1-3H3;12H,4-11H2,1-3H3;2*10H,6-9H2,1-5H3;5-8H2,1-4H3;5-8H2,1-4H3;8,11H,4-7H2,1-3H3;4-7H2,1-3H3;4-7H2,1-3H3 |
| InChIKey | BRQWYUJIMSUTIE-UHFFFAOYSA-N |
| XLogP | 19.14 |
| TPSA | 198.56 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 187 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2647.40 |
| LogP ≤ 5 | 19.14 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 33 |